Sumitomo Dainippon Pharma Annual Report 2017
68/102

$ 637,580 305,313 23,839 973,473150,170 (36) 1,147,446 614,348 544,250 112,2593,361,196 55,938854,696 999,455 27,795 1,937,884 (1,408,830) 529,05416,670412,214808,6161,731,884176,5625,7776,34840,5273,198,598$ 7,088,848Millions of yenThousands ofU.S. dollars (Note 1) ¥ 54,923 81,039 2,512105,31648,513(4)156,33759,58963,9925,705421,5856,26995,280113,233 1,497216,279(154,454)61,8251,81958,61376,95060,14519,486672,3144,913224,307¥ 707,7172016 ¥ 71,409 34,195 2,670109,02916,819(4)128,51468,80760,95612,573376,454 6,26595,726111,939 3,113217,043(157,789)59,2541,86746,16890,565193,97119,7756477114,539358,243¥ 793,951CURRENT ASSETS: Cash and time deposits (Notes 3 and 5) Marketable securities (Notes 3, 5 and 6) Receivables: Trade notes (Note 5) Trade accounts (Note 5) Due from parent company, unconsolidated subsidiaries and afliates (Notes 5 and 13) Allowance for doubtful receivables Total Inventories (Note 4) Deferred tax assets (Note 9) Other current assets Total current assetsPROPERTY, PLANT AND EQUIPMENT: Land Buildings and structures Machinery and equipment Construction in progress Total Accumulated depreciation Net property, plant and equipmentINVESTMENTS AND OTHER ASSETS: Investment in unconsolidated subsidiaries and afliates (Notes 5) Investment securities (Notes 5 and 6) Goodwill (Note 15) In-process research and development (Note 15) Other intangible assets Asset for retirement benets (Note 10) Deferred tax assets (Note 9) Other assets Total investments and other assetsTOTALASSETS20172017Financial SectionConsolidated Balance SheetsSumitomo Dainippon Pharma Co., Ltd. and Consolidated SubsidiariesMarch 31, 2017 and 2016Sumitomo Dainippon Pharma Co., Ltd. Annual Report 201767

元のページ  ../index.html#68

このブックを見る